JPWO2020053239A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020053239A5
JPWO2020053239A5 JP2021537505A JP2021537505A JPWO2020053239A5 JP WO2020053239 A5 JPWO2020053239 A5 JP WO2020053239A5 JP 2021537505 A JP2021537505 A JP 2021537505A JP 2021537505 A JP2021537505 A JP 2021537505A JP WO2020053239 A5 JPWO2020053239 A5 JP WO2020053239A5
Authority
JP
Japan
Prior art keywords
sequence
seq
fusion protein
antibody
mutations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021537505A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022500076A (ja
JP7623006B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/074153 external-priority patent/WO2020053239A1/en
Publication of JP2022500076A publication Critical patent/JP2022500076A/ja
Publication of JPWO2020053239A5 publication Critical patent/JPWO2020053239A5/ja
Application granted granted Critical
Publication of JP7623006B2 publication Critical patent/JP7623006B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021537505A 2018-09-11 2019-09-11 特異的結合剤により認識されるエピトープタグ Active JP7623006B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP18193663 2018-09-11
EP18193663.4 2018-09-11
EP19160485.9 2019-03-04
EP19160485 2019-03-04
PCT/EP2019/074153 WO2020053239A1 (en) 2018-09-11 2019-09-11 Epitope tags recognized by specific binders

Publications (3)

Publication Number Publication Date
JP2022500076A JP2022500076A (ja) 2022-01-04
JPWO2020053239A5 true JPWO2020053239A5 (enExample) 2022-09-16
JP7623006B2 JP7623006B2 (ja) 2025-01-28

Family

ID=68138006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021537505A Active JP7623006B2 (ja) 2018-09-11 2019-09-11 特異的結合剤により認識されるエピトープタグ

Country Status (5)

Country Link
US (1) US12365705B2 (enExample)
EP (1) EP3849996A1 (enExample)
JP (1) JP7623006B2 (enExample)
CN (1) CN113195516B (enExample)
WO (1) WO2020053239A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250154202A1 (en) * 2022-02-02 2025-05-15 BioNTech SE Cyclic epitope tags
AU2023216437A1 (en) * 2022-02-02 2024-08-15 BioNTech SE Agents and methods for targeted delivery of nucleic acids to cells
AU2023215613A1 (en) * 2022-02-02 2024-08-08 BioNTech SE Agents and methods for targeted delivery to cells
WO2023222580A1 (en) 2022-05-16 2023-11-23 Byondis B.V. Novel masked antibodies
CN117802045A (zh) 2022-09-30 2024-04-02 北京恩康医药有限公司 一种工程化细胞外囊泡的构建及其应用
WO2024172152A1 (ja) * 2023-02-17 2024-08-22 国立大学法人 東京大学 細胞外小胞の運命記録システム
WO2025021277A1 (en) * 2023-07-21 2025-01-30 BioNTech SE Agents and methods for targeted delivery of cytokines to immune cells
EP4520768A1 (en) 2023-09-06 2025-03-12 BioNTech SE Vhh-ch3 fusion proteins
WO2025078418A1 (en) 2023-10-10 2025-04-17 Nano Tag Biotechnologies Gmbh Humanized single-domain antibodies binding to epitope tags
TW202535921A (zh) 2023-10-11 2025-09-16 德商拜恩迪克公司 用於靶向遞送免疫效應子細胞之試劑及方法
WO2025219955A1 (en) * 2024-04-17 2025-10-23 BioNTech SE Soluble tcrs and methods of use thereof
CN120923600A (zh) * 2024-05-09 2025-11-11 福建医科大学 一种超稳定红色荧光蛋白
CN118909142A (zh) * 2024-08-07 2024-11-08 北京爱思益普生物科技股份有限公司 Irak4蛋白的制备方法及其所采用的融合蛋白

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE427968T1 (de) 1992-08-21 2009-04-15 Univ Bruxelles Immunoglobuline ohne leichtkette
US20040014955A1 (en) * 2001-12-17 2004-01-22 Carlos Zamudio Identification of essential genes of cryptococcus neoformans and methods of use
EP1558650A2 (en) * 2002-11-08 2005-08-03 Ablynx N.V. Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders
AR067584A1 (es) * 2007-07-20 2009-10-14 Hoffmann La Roche Un conjugado de un anticuerpo contra la cd4 y peptidos antifusogenicos
US7678883B2 (en) * 2007-07-25 2010-03-16 E.I. Du Pont De Nemours And Company Solubility tags for the expression and purification of bioactive peptides
GB201008682D0 (en) 2010-05-25 2010-07-07 Vib Vzw Epitope tag for affinity based applications
US10308679B2 (en) * 2014-11-03 2019-06-04 Merck Patent Gmbh Soluble intein fusion proteins and methods for purifying biomolecules
EP3168306A1 (en) 2015-11-16 2017-05-17 ChromoTek GmbH Epitope tag and method for detection and/or purification of tagged polypeptides

Similar Documents

Publication Publication Date Title
JPWO2020053239A5 (enExample)
Kipriyanov et al. Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment–core streptavidin fusion
JP2020186248A5 (enExample)
Dübel et al. Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv)
JP7623006B2 (ja) 特異的結合剤により認識されるエピトープタグ
JP2019521643A5 (enExample)
JP2019514361A5 (enExample)
US11384141B2 (en) Serum albumin binding antibodies for tuneable half-life extension of biologics
JP2020530293A5 (enExample)
CA2561826A1 (en) Linear single chain recombinant anti-cea/cd3/cd28 trispecific antibody
WO2003046560B1 (en) Self-assembly molecules
JP2001521496A (ja) 高い結合活性の多価および多特異的試薬
WO2021092075A1 (en) IL-2RβγC BINDING COMPOUNDS
WO2009142773A4 (en) Multivalent fibronectin based scaffold domain proteins
WO2005075507A1 (en) Amyloid beta peptide binding polypeptide
CN102686611A (zh) 与“渐进性糖化终产物受体”结合的多肽以及包括所述多肽的组合物和方法
JP2017501728A5 (enExample)
JP2019535262A5 (enExample)
RU2016149596A (ru) Новые полипептиды со специфическим связыванием и пути их применения
CN105658228B (zh) 结合人类补体c5的稳定多肽
JP2009525725A (ja) 血小板抗原特異抗体の結合を中和するペプチドアプタマー並びにそれを含む診断及び治療への応用
WO2021207613A1 (en) Frb antibodies
CN115433277A (zh) 抗cd38兔重组单克隆抗体的制备及应用
JPWO2022183074A5 (enExample)
CN107629112B (zh) 一种高亲和性lc3蛋白靶向肽及其应用